Development of a balanced dual PI3K/mTOR kinase inhibitor: A new generation of potential drugs for targeted cancer therapy | RVO.nl | Rijksdienst

Service menu right

Development of a balanced dual PI3K/mTOR kinase inhibitor: A new generation of potential drugs for targeted cancer therapy